Published in Clin Pharmacol Ther on June 01, 1987
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00
Flow cytometry of apoptotic cell death. J Immunol Methods (2000) 2.30
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. J Clin Oncol (1989) 2.12
Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab (1995) 2.03
Genetic complementation analysis of ataxia telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet Cell Genet (1988) 1.88
Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet (1999) 1.63
Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells. Exp Hematol (1991) 1.41
[Decision support in primary care--a vertical second opinion]. Ned Tijdschr Geneeskd (2001) 1.39
[Protocol in paraproteinemias]. Ned Tijdschr Geneeskd (1991) 1.39
Clinical course in 28 unselected patients with aplastic anaemia treated with anabolic steroids. Br J Haematol (1979) 1.39
Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol (1988) 1.38
Clinical pharmacokinetics of doxorubicin. Clin Pharmacokinet (1988) 1.37
Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab (2001) 1.18
In addition to von Willebrand factor and urinary albumin excretion, plasma endothelin is an indicator of endothelial dysfunction in diabetes mellitus. Diabetologia (1993) 1.09
A method for quantification of peripheral blood admixture in bone marrow aspirates. Exp Hematol (1980) 1.09
Apoptosis and programmed cell death in health and disease. Adv Clin Chem (1994) 1.04
Clinical course and survival in 16 patients with localized plasmacytoma. Scand J Haematol (1984) 1.02
Improvement of erythropoiesis during treatment with deferiprone in a patient with myelofibrosis and transfusional hemosiderosis. Am J Hematol (1996) 1.01
Apoptotic cell death kinetics in vitro depend on the cell types and the inducers used. Apoptosis (2004) 1.01
A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients. Antimicrob Agents Chemother (1985) 1.01
Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy. A study of 293 patients. Blood (1982) 0.98
Hageman factor, a novel sialoglycoprotein with esterase activity. Biochim Biophys Acta (1965) 0.96
The effect of lithium on platelet aggregation and platelet release reaction. Thromb Res (1977) 0.96
Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients. Cancer Chemother Pharmacol (1987) 0.94
Early features of apoptosis detected by four different flow cytometry assays. Apoptosis (1998) 0.94
A simple test for measuring platelet aggregation. Results in von Willebrand's disease and uraemia. Thromb Diath Haemorrh (1969) 0.94
Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry. Blood (1992) 0.92
Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells. Exp Cell Res (1988) 0.91
Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci (1997) 0.91
The immunoglobulins in Hodgkin's disease. Eur J Cancer (1976) 0.91
Pharmacokinetics of cytosine arabinoside in acute myeloid leukemia. Clin Pharmacol Ther (1977) 0.91
Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chemother Pharmacol (1987) 0.90
Treatment of acute lymphoblastic leukemia in adolescents and a-dults: A retrospective study of 41 patients (1970-1973). Blood (1975) 0.90
Clinical course and survival after elective splenectomy in 19 patients with primary myelofibrosis. Br J Haematol (1977) 0.89
Monocyte purification with counterflow centrifugation monitored by continuous flow cytometry. J Immunol Methods (1981) 0.88
Familial thrombopathic thrombocytopenia. Br J Haematol (1968) 0.88
Simultaneous measurement of DNA content and cell-surface immunofluorescence of human bone marrow cells using a single laser flow cytometer. Cytometry (1990) 0.88
Apoptosis and secondary necrosis of lymphocytes in culture. Acta Haematol (1997) 0.87
Sporadic mutations of the p53 gene in multiple myeloma and no evidence for germline mutations in three familial multiple myeloma pedigrees. Leukemia (1993) 0.87
Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent. Thromb Diath Haemorrh (1967) 0.87
Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. Bone Marrow Transplant (1994) 0.87
Platelet function and von Willebrand's disease. Lancet (1968) 0.86
Detection of point mutations in DNA using capillary electrophoresis in a polymer network. J Chromatogr (1993) 0.86
Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model. Cancer Chemother Pharmacol (1998) 0.85
Cytosine arabinoside binding to human plasma proteins. Arch Int Pharmacodyn Ther (1977) 0.85
Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery. Gut (1988) 0.85
Blastomycosis treated successfully with miconazole. Trop Geogr Med (1979) 0.85
Simplified method for DNA and protein staining of human hematopoietic cell samples. Cytometry (1981) 0.85
Observations on platelet ultrastructure in familial thrombocytopathic thrombocytopenia. Am J Pathol (1968) 0.84
Chronic lymphocytic leukaemia presenting as renal failure with lymphocytic infiltration of the kidneys. Neth J Med (1992) 0.84
Rapid quantitative determination of four anthracyclines and their main metabolites in human nucleated haematopoietic cells. J Chromatogr (1986) 0.83
Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography. Cytometry (1985) 0.83
Evaluation of lay skills in cardiopulmonary resuscitation. Br Heart J (1985) 0.83
Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis. Thromb Haemost (1995) 0.83
Cellular pharmacokinetics of daunomycin administered as continuous intravenous infusion in the treatment of acute non-lymphocytic leukaemia. Br J Haematol (1986) 0.82
Different susceptibilities of normal T cells and T cell lines to immunotoxins. Scand J Immunol (1988) 0.82
Effect of acarbose, pectin, a combination of acarbose with pectin, and placebo on postprandial reactive hypoglycaemia after gastric surgery. Gut (1983) 0.82
Significance of fibrin split products in patients with renal failure. Scand J Haematol Suppl (1971) 0.82
Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Blood (1989) 0.81
Preparation and clinical use of factor IX concentrate PPSB according to Soulier. Vox Sang (1969) 0.81
Bone-marrow-profileration patterns in acute myeloblastic leukaemia determined by pulse cytophotometry. Lancet (1975) 0.81
Endogenous mediators in sepsis and septic shock. Adv Clin Chem (1998) 0.81
"Incubation period" in Hodgkin's disease. Lancet (1975) 0.80
First-trimester prenatal diagnosis of the Nijmegen breakage syndrome and ataxia telangiectasia using an assay of radioresistant DNA synthesis. Prenat Diagn (1990) 0.80
Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation. Transplantation (1984) 0.80
Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma. Cancer Chemother Pharmacol (1986) 0.80
Combined immunodeficiency preceding chronic lymphocytic leukemia. Blut (1984) 0.80
Sequential occurrence of mitochondrial and plasma membrane alterations, fluctuations in cellular Ca2+ and pH during initial and later phases of cell death. Apoptosis (1999) 0.80
A case of gamma-heavy chain monoclonal gammopathy of undetermined significance. Neth J Med (1984) 0.80
Hormonal dependent thrombotic thrombocytopenic purpura (TTP). Scand J Haematol (1983) 0.80
A hereditary abnormal c-fms proto-oncogene in a patient with acute lymphocytic leukaemia and congenital hypothyroidism. Br J Haematol (1985) 0.79
[Familial colon carcinoma]. Ned Tijdschr Geneeskd (1984) 0.79
Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's disease. Eur J Cancer Clin Oncol (1983) 0.79
A new multichamber counterflow centrifugation rotor with high-separation capacity and versatile potentials. Exp Hematol (1988) 0.79
In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells. Eur J Cancer Clin Oncol (1988) 0.79
Treatment of Pseudomonas aeruginosa septicemia in neutropenic patients with ceftazidime. Eur J Clin Microbiol (1985) 0.78
Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease. Eur J Clin Invest (1977) 0.78
Human T lymphocyte differentiation antigens as target for immunotoxins or complement-mediated cytotoxicity. Scand J Immunol (1988) 0.78
Influence of lithium on aggregation, release-reaction and function of human platelets. Pathol Biol (Paris) (1972) 0.78
Peripheral blood cell harvests yield primitive multilineage progenitor cells in the CD34+/33- fraction. Int J Artif Organs (1993) 0.78
Variations of the phosphorylation of 1-beta-D-arabinofuranosylcytosine (ARA-C) in human myeloid leukemic cells related to the cell cycle. Leuk Res (1982) 0.78
Flow cytometric determination of the S-phase compartment in adult acute leukemia. Acta Haematol (1983) 0.78
In vitro effects of estradiol, dydrogesterone, tamoxifen and cyclophosphamide on proliferation vs. death in human breast cancer cells. Cancer Lett (2003) 0.78
A phase I study of intraarterial iododeoxyuridine in patients with colorectal liver metastases. J Clin Oncol (1989) 0.78